Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1997-01-10
1998-08-18
Saunders, David
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435 4, 435 6, 435 8, 536 235, C12Q 102, C12Q 166, C12Q 168, C07H 2104
Patent
active
057957266
ABSTRACT:
Methods for identifying compounds, which modulate the bioactivity of human hepatic nuclear factor-1 (HNF-1), and which are therefore useful in treating type II diabetes are disclosed.
REFERENCES:
Byrne, Maria M. et al., "Altered Insulin Secretory Responses to Glucose in Diabetic and Nondiabetic Subjects with Mutations in the Diabetes Susceptibility Gene MODY3 on Chromosome 12", Diabetes 45:1503-1510, Nov. 1996.
Fajans, Stefan S. et al., "Maturity-Onset Diabetes of the Young", Life Sciences, 6(55):413-422, 1994.
Vaxillaire, Martine et al., "A Gene for Maturity Onset Diabetes of the Young (MODY) Maps to Chromosome 12q", Natural Genetics 9:418-423, Apr. 1995.
Zhong, Weimin et al., "Tissue-Specific Regulation of Mouse Hepatocyte Nuclear Factor 4 Expression", Molecular and Cellular Biology 11(14):7276-7284, Nov. 1994.
Barrera-Hernandez, Gonzalo et al., "Effects of Diabetes Mellitus on Hepatocyte Nuclear Factor 1 Decrease Albumin Gene Transcription", The Journal of Biological Chemistry, 17(271):9969-9975, Apr. 1996.
Bach, Ingolf and Yaniv, Moshe "More Potent Transcriptional Activators or a Transdominant Inhibitor of the HNF1 Homeoprotein Family are Generated by Alternative RNA Processing", The EMBO Journal, 11(12)4229-4242 (and corrigendum), 1993.
Ringeisen, Fran.cedilla.ois, et al., "The Transactivation Potential of Variant Hepatocyte Nuclear Factor 1 is Modified by Alternative Splicing", The Journal of Biological Chemistry 34(268):25706-25711, 1992.
Stoffel, Markus et al. "A Yeast Artificial Chromosome-Based Map of the Region of Chromosome 20 Containing the Diabetes-Susceptibility Gene, MODY1, and a Myeloid Leukemia Related Gene", Proc. Natl. Acad. Sci., USA 93:3937-3941, 1996.
Bryne, Maria M. et al., "Altered Insulin Secretory Responses to Glucose in Subjects with a Mutation in the MODY1 Gene on Chromosome 20", Diabetes 44:699-704, 1995.
Vaxillaire, Martine et al., "Search for a Third Susceptibility Gene for Maturity-Onset Diabetes of the Young", Diabetes 43:389-395, 1994.
Drewes, Thorsten et al. "Human Hepatocyte Nuclear Factor 4 Isoforms are Encoded by Distinct and Differentially Expressed Genes" Molecular and Cellular Biology 3(16):925-931, 1996.
Beck-Nielsen, Henning et al., "Insulin Action and Insulin Secretion in Identical Twins with MODY", Diabetes 37:730-735, 1988.
Lesage, Suzanne, et al. "Linkage Analyses of the MODY3 Locus on Chromosome 12q with Late-Onset NIDDM", Diabetes 44:1243-1247, 1995.
Arnold, Esq. Beth E.
Millennium Pharmaceuticals Inc.
Saunders David
VanderVegt F. Pierre
LandOfFree
Methods for identifying compounds useful in treating type II dia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for identifying compounds useful in treating type II dia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for identifying compounds useful in treating type II dia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1113689